AXQ Capital’s Medifast MED Stock Holding History

AXQ Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,325	Closed	-$214K	–	548
2023 Q2	$214K	Buy	+2,325	New	+$207K	0.26%	189

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AXQ Capital's MED Position: Q3 2023 in Review

AXQ Capital sold out of Medifast (MED) in Q3 2023, closing a stake of 2,325 shares — an estimated $214K sold.

AXQ Capital first reported a position in MED in Q2 2023 and held it in 1 quarter. The position peaked at $214K in Q2 2023. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

AXQ Capital reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
AXQ Capital sold 2,325 Medifast shares in Q3 2023, an estimated $214K.
AXQ Capital first reported a position in Medifast in Q2 2023 and held it in 1 quarter.
AXQ Capital's Medifast position peaked at $214K in Q2 2023.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on AXQ Capital's 13F filing for Q3 2023, filed 14 Nov 2023.